RE-KneewTM is an autologous human adipose-derived mesenchymal stem cell (haMPC) therapy developed to address knee osteoarthritis. The advanced proprietary process isolates & excites regenerative cells, which effects may include regeneration of cartilage and reduction of inflammation and degeneration.
RE-KneewTM has completed clinical trials in China and is on the market.
